F673-0232 Screening compound: 4-(4-methyl-3-oxo-3,4-dihydropyrido[2,3-b]pyrazin-2-yl)-N~1~-(tetrahydro-2-furanylmethyl)tetrahydro-1(2H)-pyrazinecarboxamide

F673-0232 Screening compound: 4-(4-methyl-3-oxo-3,4-dihydropyrido[2,3-b]pyrazin-2-yl)-N~1~-(tetrahydro-2-furanylmethyl)tetrahydro-1(2H)-pyrazinecarboxamide
F673-0232 Screening compound: 4-(4-methyl-3-oxo-3,4-dihydropyrido[2,3-b]pyrazin-2-yl)-N~1~-(tetrahydro-2-furanylmethyl)tetrahydro-1(2H)-pyrazinecarboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F673-0232
4-(4-methyl-3-oxo-3,4-dihydropyrido[2,3-b]pyrazin-2-yl)-N~1~-(tetrahydro-2-furanylmethyl)tetrahydro-1(2H)-pyrazinecarboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F673-0232

Molecular Formula

C18H24N6O3 (C18 H24 N6 O3)

Compound Name

4-(4-methyl-3-oxo-3,4-dihydropyrido[2,3-b]pyrazin-2-yl)-N~1~-(tetrahydro-2-furanylmethyl)tetrahydro-1(2H)-pyrazinecarboxamide

IUPAC name

n/a

SMILES

CN(c1ncccc1N=C1N(CC2)CCN2C(NCC2OCCC2)=O)C1=O

InChI

InChI=1S/C18H24N6O3/c1-22-15-14(5-2-6-19-15)21-16(17(22)25)23-7-9-24(10-8-23)18(26)20-12-13-4-3-11-27-13/h2,5-6,13H,3-4,7-12H2,1H3,(H,20,26)/t13-/m1/s1

InChI Key

RTGVZRIHKYFKOJ-CYBMUJFWSA-N

MDL Number (MFCD)

MFCD28119638

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

372.43

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

-0.314

Distribution Coefficient, logD

-0.316

Water Solubility, LogSw

-1.58

Polar Surface Area

71.842

Acid Dissociation Constant (pKa)

15.70

Base Dissociation Constant (pKb)

4.85

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

55.60

F673-0232 in Drug Discovery

Included in Screening Libraries

Protein Arginine Methyltransferases Library (27925 compounds)

Soluble Diversity Library (15920 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with F673-0232 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F673-0232?
Check Price and Availability of F673-0232, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F673-0232 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F673-0232
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F673-0232
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F673-0232 available by request